⚡Bharat Biotech’s COVID-19 Vaccine Covaxin Shows 77.8% Efficacy in Phase III Trials, Say Sources
By ANI
Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.